-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The Joint Procurement Office previously notified that the results of the seventh batch of national procurement will be implemented in November 2022, and the specific implementation date is subject to the notice issued by each locality
.
Hainan has made it clear that the seventh batch of national mining will be officially implemented by the end of November 2022
.
.
Hainan has made it clear that the seventh batch of national mining will be officially implemented by the end of November 2022
.
In addition, Hainan will also implement the fourth batch of collection and mining in eight provinces and two districts (led by Liaoning Province) and the collection and mining of Hubei Proprietary Chinese Medicine Alliance (second batch) in batches by the end of December
.
The fifth batch of drugs will be carried out in the form of participating in the inter-provincial alliance and the provincial organization, and the results
of the selection are expected to be officially implemented around the end of December.
.
The fifth batch of drugs will be carried out in the form of participating in the inter-provincial alliance and the provincial organization, and the results
of the selection are expected to be officially implemented around the end of December.
Beijing also announced the upper limit
of the quotation of the first, second and fourth batches of national drug continuation related products.
of the quotation of the first, second and fourth batches of national drug continuation related products.
On July 18, the National Joint Procurement Office issued a notice
of the results of the seventh batch of national procurement selection.
of the results of the seventh batch of national procurement selection.
The announcement said that the results of the selection will be implemented in November 2022, and the specific implementation date is subject to the notice issued by various localities
.
The collection of 60 kinds of drugs successfully purchased, the average price of selected drugs reduced by 48%, involving 31 treatment categories, not only including hypertension, diabetes, anti-infection, digestive tract diseases and other common diseases, chronic disease drugs, but also including lung cancer, liver cancer, kidney cancer, bowel cancer and other major diseases, according to the agreed purchase amount, it is expected to save 18.
5 billion yuan per year.
.
The collection of 60 kinds of drugs successfully purchased, the average price of selected drugs reduced by 48%, involving 31 treatment categories, not only including hypertension, diabetes, anti-infection, digestive tract diseases and other common diseases, chronic disease drugs, but also including lung cancer, liver cancer, kidney cancer, bowel cancer and other major diseases, according to the agreed purchase amount, it is expected to save 18.
5 billion yuan per year.
On July 22, Tianjin issued a notice that the seventh batch of national centralized drug procurement information maintenance and the online signing of tripartite agreements will be carried
out.
out.
On August 2, the Guangdong Provincial Platform issued a notice that the seventh batch of national collection and selection of drugs will be declared and the distribution relationship maintenance will be carried out
.
.
The notices issued by each province on the implementation of the seventh batch of national procurement are summarized as follows:
On September 28, the Hainan Provincial Medical Security Bureau issued a pre-notice on the implementation of the centralized procurement of drugs organized by the national and interprovincial alliances
.
.
Hainan Province will land before the end of the year and will soon implement the results of the collection and selection
National Collection: The seventh batch of national procurement is expected to issue an implementation plan around the end of October, and the results
of the selection will be formally implemented around the end of November.
Please do a good job in the selected drugs on the network, and notify the relevant pharmaceutical manufacturers to prepare for stockpiling
.
of the selection will be formally implemented around the end of November.
Please do a good job in the selected drugs on the network, and notify the relevant pharmaceutical manufacturers to prepare for stockpiling
.
Inter-provincial alliance collection: Guangdong Inter-provincial Alliance Western medicine, proprietary Chinese medicine, common diseases and chronic disease drugs centralized procurement, it is planned to complete the confirmation of the amount to be allocated around the end of October, issue the implementation plan around the end of November, and implement the selection results
in batches around the end of December.
The fourth batch of interprovincial alliances of eight provinces and two districts (led by Liaoning Province) and the collection and procurement of Hubei proprietary Chinese medicine alliance (second batch) are implemented in accordance with the unified steps of the
alliance.
in batches around the end of December.
The fourth batch of interprovincial alliances of eight provinces and two districts (led by Liaoning Province) and the collection and procurement of Hubei proprietary Chinese medicine alliance (second batch) are implemented in accordance with the unified steps of the
alliance.
The upcoming collection and continuation work
The fifth batch of drugs in national procurement plans to carry out continuation work by participating in the combination of inter-provincial alliances and provincial organizations, and it is expected to officially implement the results of the selection around the end of December
.
In order to ensure the continuity of the procurement of selected drugs and ensure clinical use, the renewal and use of selected varieties is carried out in accordance with the principle of "ensuring supply and follow-up contract"
.
.
In order to ensure the continuity of the procurement of selected drugs and ensure clinical use, the renewal and use of selected varieties is carried out in accordance with the principle of "ensuring supply and follow-up contract"
.
Before the successive selected enterprises are determined, the medical institutions shall first purchase and use the drugs supplied by the original selected drug manufacturers and drug distribution enterprises normally at the selected price, and the payment price of medical insurance drugs (including the selected and non-selected) shall continue to extend the standards determined in the first procurement year (except for the problem varieties found in the cleanup).
For drugs that cannot be normally supplied by the original selected enterprises, medical institutions should give priority to purchasing other drugs
with low prices and high quality.
After the selected enterprises are determined, the results and implementation time of the centralized procurement in the next procurement year will be determined separately, and the agreement of the newly selected enterprises will be completed and the payment standards
will be adjusted.
If the original selected drug manufacturer cannot supply normally until the end of December, please feedback to the Provincial Public Resources Trading Service Center before October 20, so that our province can start the replacement procedure
, and those who have not given feedback within the time limit are deemed to be able to supply normally.
with low prices and high quality.
After the selected enterprises are determined, the results and implementation time of the centralized procurement in the next procurement year will be determined separately, and the agreement of the newly selected enterprises will be completed and the payment standards
will be adjusted.
If the original selected drug manufacturer cannot supply normally until the end of December, please feedback to the Provincial Public Resources Trading Service Center before October 20, so that our province can start the replacement procedure
, and those who have not given feedback within the time limit are deemed to be able to supply normally.
【Interprovincial Alliance Centralized Procurement Continuation】The first batch of interprovincial alliances of Shaanxi Eleven Provinces, the interprovincial alliance of eight provinces and two districts (led by Sichuan), and the centralized procurement of drugs in Chongqing Alliance will be renewed in accordance with the unified arrangement of the leading province and combined with the actual situation in Hainan, and the continuation time is to be determined
.
.
During this period, the payment price of medical insurance drugs (including selected and non-selected) will continue to extend the standards determined in the previous procurement year (except for the problem varieties found in the cleanup), and the drug supply, procurement and other policies shall refer to the fifth batch
of national collection in this notice.
The varieties that were originally included in the inter-provincial alliance collection of Hainan Province and later adopted by the state were subsequently transferred to the results of the selection of the bidding countries
.
of national collection in this notice.
The varieties that were originally included in the inter-provincial alliance collection of Hainan Province and later adopted by the state were subsequently transferred to the results of the selection of the bidding countries
.
Collection of drug balance retention assessment and reward work: will rely on the medical insurance information platform recruitment subsystem of the balance retention assessment module to carry out, has completed the system simulation test, due to the epidemic caused by the postponement of the assessment work, it is expected to complete the first batch of national procurement to the fourth batch, the Shaanxi Provincial Alliance and the eight provinces and two districts inter-provincial alliance of the first batch (Sichuan leading) collection of drug procurement and use balance retention assessment
.
.
Beijing: The first, second and fourth batches of national mining continued to limit the price publicity
At the same time, on September 28, Beijing also issued the "Notice on Publicizing the Matters Related to the Quotation Ceiling of the First, Second and Fourth Batches of National Centralized
Procurement Drugs".
Procurement Drugs".
Publicity time: 10:00 on September 29, 2022 to 16:00 on October 8, 2022
.
.
Publicity viewing method: Enterprises can log on to the Beijing Medical Security Information Platform - Drug and Consumables Recruitment and Management Subsystem, select "Procurement with Volume - Publicity of the Upper Limit of Successive Quotations of One, Two and Four Batches", and view the content of the publicity, for specific operations, see the "Operation Manual for the Publicity of the First, Second and Fourth Batches of Successive Quotation Ceilings"
.
.
Quotation ceiling, transaction reference price formulation:
For products with the selected price of the provincial or inter-provincial alliance after the expiration of the national harvest, the minimum selected price of the product with quantity procurement shall be used as the upper limit
of the quotation.
of the quotation.
Products without the selected price of provincial or inter-provincial alliance after the expiration of national mining, which belong to the selected products in the previous round of national mining, and the price of the product in the previous round of national mining is used as the upper limit of the quotation;
For other products, the lowest price selected in the purchase of the same group of products is the upper limit
of the quotation.
of the quotation.
